486 related articles for article (PubMed ID: 29505580)
21. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
[TBL] [Abstract][Full Text] [Related]
22. One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.
Richards F; Rizzo N; Diaz Espinoza CE; Monroy ZM; Crovella Valdez CG; de Cabrera RM; de Leon O; Zea-Flores G; Sauerbrey M; Morales AL; Rios D; Unnasch TR; Hassan HK; Klein R; Eberhard M; Cupp E; Domínguez A
Am J Trop Med Hyg; 2015 Dec; 93(6):1295-304. PubMed ID: 26503275
[TBL] [Abstract][Full Text] [Related]
23. Onchocerciasis in the Amazonian focus of southern Venezuela: altitude and blackfly species composition as predictors of endemicity to select communities for ivermectin control programmes.
Vivas-Martinez S; Basáñez MG; Grillet ME; Weiss H; Botto C; García M; Villamizar NJ; Chavasse DC
Trans R Soc Trop Med Hyg; 1998; 92(6):613-20. PubMed ID: 10326102
[TBL] [Abstract][Full Text] [Related]
24. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
25. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
27. On-going transmission of human onchocerciasis in the Massangam health district in the West Region of Cameroon: Better understanding transmission dynamics to inform changes in programmatic interventions.
Bakajika D; Senyonjo L; Enyong P; Oye J; Biholong B; Elhassan E; Boakye D; Dixon R; Schmidt E
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006904. PubMed ID: 30427830
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.
Gómez-Priego A; Mendoza R; de-la-Rosa JL
Clin Diagn Lab Immunol; 2005 Jan; 12(1):40-3. PubMed ID: 15642982
[TBL] [Abstract][Full Text] [Related]
29. Polymerase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico.
Rodríguez-Pérez MA; Lilley BG; Domínguez-Vázquez A; Segura-Arenas R; Lizarazo-Ortega C; Mendoza-Herrera A; Reyes-Villanueva F; Unnasch TR
Am J Trop Med Hyg; 2004 Jan; 70(1):38-45. PubMed ID: 14971696
[TBL] [Abstract][Full Text] [Related]
30. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal.
Dieye Y; Storey HL; Barrett KL; Gerth-Guyette E; Di Giorgio L; Golden A; Faulx D; Kalnoky M; Ndiaye MKN; Sy N; Mané M; Faye B; Sarr M; Dioukhane EM; Peck RB; Guinot P; de Los Santos T
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005884. PubMed ID: 28972982
[TBL] [Abstract][Full Text] [Related]
33. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
34. Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico.
Rodríguez-Pérez MA; Katholi CR; Hassan HK; Unnasch TR
Am J Trop Med Hyg; 2006 Jun; 74(6):1026-33. PubMed ID: 16760515
[TBL] [Abstract][Full Text] [Related]
35. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
36. The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.
Katabarwa MN; Zarroug IMA; Negussu N; Aziz NM; Tadesse Z; Elmubark WA; Shumo Z; Meribo K; Kamal H; Mohammed A; Bitew Y; Seid T; Bekele F; Yilak A; Endeshaw T; Hassen M; Tillahun A; Samuel F; Birhanu H; Asmare T; Boakye D; Feleke SM; Unnasch T; Post R; Higazi T; Griswold E; Mackenzie C; Richards F
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007830. PubMed ID: 32027648
[TBL] [Abstract][Full Text] [Related]
37. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted.
Katabarwa M; Lakwo T; Habomugisha P; Agunyo S; Byamukama E; Oguttu D; Ndyomugyenyi R; Tukesiga E; Ochieng GO; Abwaimo F; Onapa A; Lwamafa DW; Walsh F; Unnasch TR; Richards FO
Am J Trop Med Hyg; 2014 Jun; 90(6):1159-66. PubMed ID: 24686740
[TBL] [Abstract][Full Text] [Related]
38. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
Adewale B; Oyerinde JP; Mafe MA
West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
[TBL] [Abstract][Full Text] [Related]
39. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
Traore MO; Sarr MD; Badji A; Bissan Y; Diawara L; Doumbia K; Goita SF; Konate L; Mounkoro K; Seck AF; Toe L; Toure S; Remme JH
PLoS Negl Trop Dis; 2012; 6(9):e1825. PubMed ID: 23029586
[TBL] [Abstract][Full Text] [Related]
40. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
